Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vega Masignani

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Expert Opinion on Biological Therapy|January 9, 2003
Reverse vaccinology: a genome-based approach for vaccine developmentVega Masignani, Rino Rappuoli, Mariagrazia Pizza
Drug Discovery Today|May 29, 2007
The pan-genome: towards a knowledge-based discovery of novel targets for vaccines and antibacterialsAlessandro Muzzi, Vega Masignani, Rino Rappuoli
Vaccine|May 24, 2003
The value of vaccinesVega Masignani, Maria Lattanzi, Rino Rappuoli
EMBO Molecular Medicine|September 6, 2024
Next generation of "magic bullets", solutions from the microbial pangenomeVega Masignani, Rino Rappuoli, Mariagrazia Pizza
Frontiers in Immunology|May 2, 2019
The Development of a Vaccine Against Meningococcus B Using Reverse VaccinologyVega Masignani, Mariagrazia Pizza, E Richard Moxon
Nature Reviews. Microbiology|March 11, 2005
Opinion: Cell entry machines: a common theme in nature?Michèle A Barocchi, Vega Masignani, Rino Rappuoli
Expert Review of Vaccines|April 5, 2017
Emerging experience with meningococcal serogroup B protein vaccinesDaniela Toneatto, Mariagrazia Pizza, Vega Masignani, et al.
Expert Review of Vaccines|December 22, 2006
Towards a universal group B Streptococcus vaccine using multistrain genome analysisHervé Tettelin, Duccio Medini, Claudio Donati, et al.
Vaccine|February 10, 2009
Genome-based approaches to develop vaccines against bacterial pathogensDavide Serruto, Laura Serino, Vega Masignani, et al.
Expert Review of Vaccines|November 21, 2018
Meningococcal B vaccine (4CMenB): the journey from research to real world experienceRino Rappuoli, Mariagrazia Pizza, Vega Masignani, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Expert Opinion on Biological Therapy|January 9, 2003
Reverse vaccinology: a genome-based approach for vaccine developmentVega Masignani, Rino Rappuoli, Mariagrazia Pizza
Drug Discovery Today|May 29, 2007
The pan-genome: towards a knowledge-based discovery of novel targets for vaccines and antibacterialsAlessandro Muzzi, Vega Masignani, Rino Rappuoli
Vaccine|May 24, 2003
The value of vaccinesVega Masignani, Maria Lattanzi, Rino Rappuoli
EMBO Molecular Medicine|September 6, 2024
Next generation of "magic bullets", solutions from the microbial pangenomeVega Masignani, Rino Rappuoli, Mariagrazia Pizza
Frontiers in Immunology|May 2, 2019
The Development of a Vaccine Against Meningococcus B Using Reverse VaccinologyVega Masignani, Mariagrazia Pizza, E Richard Moxon
Nature Reviews. Microbiology|March 11, 2005
Opinion: Cell entry machines: a common theme in nature?Michèle A Barocchi, Vega Masignani, Rino Rappuoli
Expert Review of Vaccines|April 5, 2017
Emerging experience with meningococcal serogroup B protein vaccinesDaniela Toneatto, Mariagrazia Pizza, Vega Masignani, et al.
Expert Review of Vaccines|December 22, 2006
Towards a universal group B Streptococcus vaccine using multistrain genome analysisHervé Tettelin, Duccio Medini, Claudio Donati, et al.
Vaccine|February 10, 2009
Genome-based approaches to develop vaccines against bacterial pathogensDavide Serruto, Laura Serino, Vega Masignani, et al.
Expert Review of Vaccines|November 21, 2018
Meningococcal B vaccine (4CMenB): the journey from research to real world experienceRino Rappuoli, Mariagrazia Pizza, Vega Masignani, et al.
Pageof 8